The drug, manufactured by Roche, is currently used to treat other forms of cancer, including lung and colon cancer. That use is unaffected by the panel's recommendation. Avastin currently contributes about $6 billion to Roche's bottom line, with about a billion dollars coming from sales for the treatment ...

She's already beaten breast cancer, so motherhood should be a snap for Christina Applegate. The 38-year-old actress is expecting her first child with her fiance, Dutch musician Martyn Lenoble (mar-TAN' luh-NO'-bul). Applegate's publicist, Ame Van Iden, confirmed a report that first appeared Wednesday on People.com ...

Being a fastidious housekeeper may not be without its risks. A study published in the international journal Environmental Health found that women who used the most household cleaning products had double the rate of breast cancer as those who used the fewer cleaners. Researchers conducted telephone ...

A panel of experts on Tuesday recommended that the US Food and Drug Administration (FDA) withdraw approval of Roche's best-selling cancer drug Avastin for the treatment of breast cancer. Experts on the advisory panel voted 12 to one to recommend that the FDA remove the indication from Avastin's label that the drug be used with chemotherapy to treat ...

GAITHERSBURG, Maryland (Reuters) - A U.S. advisory panel dealt a blow to Roche Holding's multibillion-dollar cancer drug Avastin on Tuesday, urging U.S. regulators to revoke the medicine's approval for treating breast cancer. The committee voted 12-1 to recommend withdrawal of Avastin's breast cancer clearance, which would prohibit the Swiss drugmaker from promoting the drug for that ...

GAITHERSBURG, Maryland (Reuters) - A U.S. advisory panel dealt a blow to Roche Holding's multibillion-dollar cancer drug Avastin on Tuesday, urging U.S. regulators to revoke the medicine's approval for treating breast cancer. The committee voted 12-1 to recommend withdrawal of Avastin's breast cancer clearance, which would prohibit the Swiss drugmaker from promoting the drug for that ...

Federal health advisers say unanimously that a follow-up study of the Roche drug Avastin failed to show meaningful benefits for breast cancer patients. A Food and Drug Administration panel of experts voted 13-0 that the risks and side effects of Avastin outweighed its benefits when ...

CANCER DRUG QUESTIONED: The Food and Drug Administration says follow-up studies of a Roche breast cancer drug did not deliver on promising results seen in earlier trials. ACCELERATED APPROVAL: The FDA had approved the drug Avastin for breast cancer because it shrank tumors. The agency required Roche to submit follow-up studies proving the drug also helps patients live longer. EXPERT ...

Federal health scientists say follow-up studies of a Roche breast cancer drug show it failed to slow tumor growth or extend patient lives, opening the door for a potential halt in sales. The Food and Drug Administration approved Roche's blockbuster Avastin in 2008 based on ...

Republican Senate candidate Carly Fiorina on Tuesday completed reconstructive surgery following her battle with breast cancer. Fiorina is resting after completing her final surgery, according to a statement released by her chief of staff Deborah Bowker. "Carly is in good spirits and is happy to have concluded this difficult chapter in her life," Bowker said. "She is thankful to her ...